Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)
The U.S. Food and Drug Administration issued a drug safety communication on 05/30/2013 recommending “against prolonged use of magnesium sulfate to stop preterm labor (PTL) due to bone changes in exposed babies.” In September of 2013, The American Congress of Obstetrics and Gynecologists issued Commi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AIMS Press
2016-05-01
|
| Series: | AIMS Public Health |
| Subjects: | |
| Online Access: | http://www.aimspress.com/aimsph/article/800/fulltext.html |